ZAQS.ORG

Monday, October 26, 2026 9:10 AM ET

CNBC - Health

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

1 day ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

1 day ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

3 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

4 days ago

Novo's CagriSema obesity drug shows 25% weight loss in women in analysis

4 days ago

Sickle cell gene therapies offer new hope, but access remains a major challenge

9 days ago

Here's our monthly update on our 32 stocks, including 2 more names to buy

10 days ago

Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time

10 days ago

What Maven CEO Kate Ryder tells her kids every day amid AI education threat

11 days ago

Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost

11 days ago

UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs

12 days ago

Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock

13 days ago

Jim Cramer week ahead: Bank earnings, ASML and TSMC

13 days ago

For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come

17 days ago

Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday

18 days ago

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

19 days ago

Jim Cramer says Grail can run higher as FDA decision on Galleri nears

19 days ago

Russian lab worker's suspected plague death leaves experts puzzled

20 days ago

Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk

20 days ago

AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos

20 days ago

Russian lab worker dies amid plague reports. Here's what we know

20 days ago

Russia hospitalizes almost 200 people after death from plague: Reports

21 days ago

BioMarin reports five-year Pompe disease data showing durable motor function

23 days ago

Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s

23 days ago

Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion

24 days ago

De-risking rare disease drug development

24 days ago

Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock

16 days ago

$942 million: Insurer points finger at AI as suspect hospital charges appear

24 days ago

Grindr expands beyond dating with $250 million PurposeMed acquisition

25 days ago

Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial

25 days ago

Novo's Wegovy pill improves weight loss after people switch from injections

25 days ago

White House moves to block $810 million in funding through pocket rescission

29 days ago